Surface LSP-1 Is a Phenotypic Marker Distinguishing Human Classical versus Monocyte-Derived Dendritic Cells
- PMID: 32224433
- PMCID: PMC7109623
- DOI: 10.1016/j.isci.2020.100987
Surface LSP-1 Is a Phenotypic Marker Distinguishing Human Classical versus Monocyte-Derived Dendritic Cells
Abstract
Human mononuclear phagocytes comprise several subsets of dendritic cells (DCs), monocytes, and macrophages. Distinguishing one population from another is challenging, especially in inflamed tissues, owing to the promiscuous expression of phenotypic markers. Using a synthetic library of humanized llama single domain antibodies, we identified a novel surface marker for human naturally occurring monocyte-derived DCs. Our antibody targets an extra-cellular domain of LSP-1, specifically on monocyte-derived DCs, but not on other leukocytes, in particular monocytes, macrophages, classical DCs, or the recently described blood DC3 population. Our findings will pave the way for a better characterization of human mononuclear phagocytes in pathological settings.
Keywords: Molecular Biology.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests S.M., S.A., F.P., and E.S. are co-inventors of a patent entitled "New anti-LSP1 antibody" (PCT/EP2017/0761). S.M. and F.P. are co-inventors of a patent that covers the commercial use of the library (WO/2015/063331). The authors declare no other competing interest. The authors adhere to Cell Press policy on sharing materials.
Figures





References
-
- Bakdash G., Buschow S.I., Gorris M.A., Halilovic A., Hato S.V., Skold A.E., Schreibelt G., Sittig S.P., Torensma R., Duiveman-De Boer T. Expansion of A Bdca1+Cd14+ myeloid cell population in melanoma patients may attenuate the efficacy of dendritic cell vaccines. Cancer Res. 2016;76:4332–4346. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous